AADACL2 Antikörper
-
- Target Alle AADACL2 Produkte
- AADACL2 (Arylacetamide Deacetylase-Like 2 (AADACL2))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser AADACL2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Fusion protein of Human AADACL2
- Isotyp
- IgG
-
anti-Arylacetamide Deacetylase-Like 2 (AADACL2) (AA 203-401) antibody
AADACL2 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Arylacetamide Deacetylase-Like 2 (AADACL2) (AA 156-182) antibodyAADACL2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB37919 unconjugated
anti-Arylacetamide Deacetylase-Like 2 (AADACL2) (AA 1-379) antibodyAADACL2 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
- ELISA:1:2000-1:5000, IHC:1:25-1:100,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- AADACL2 (Arylacetamide Deacetylase-Like 2 (AADACL2))
- Andere Bezeichnung
- AADACL2 (AADACL2 Produkte)
- Synonyme
- EG639634 antikoerper, RGD1563197 antikoerper, arylacetamide deacetylase like 2 antikoerper, arylacetamide deacetylase-like 2 antikoerper, Aadacl2 antikoerper, AADACL2 antikoerper
- Hintergrund
-
Background: AADAC is a 45 kDa membrane-associated hydrolase highly expressed in the human liver that has been implicated in the hydrolysis of arylacetamide xenobiotics including flutamide and phenacetin.556-560AADAC is highly homologous to several related lipases, AADACL1, 2, and 4, the latter two of which remain completely unannotated. Overexpression of AADAC in a rat hepatoma cell line produces changes in cellular TG levels, apoplipoprotein B secretion, and fatty acid oxidation, but the mechanism for these effects remains unclear.561 Candidate endogenous substrates, selective inhibitors, or knockout mice have not, to our knowledge, been described for AADAC or the related enzymes AADACL2 and AADACL4.
Aliases: AADACL2Arylacetamide deacetylase-like 2 antibody, EC 3.1.1.- antibody
- UniProt
- Q6P093
-
